搜尋結果
The Longevity Revolution: Financial Trends And Opportunities In An Aging World
Forbes· 5 日前This isn't your grandparents' idea of growing old – it's a full-blown longevity ...
We're Closer Than Ever To Beating Alzheimer's. Price Controls Could Change That.
Forbes· 5 日前The drug targets amyloid, a type of protein that builds up in & ...
Viking Therapeutics stock jumps nearly 30% after drugmaker moves weight loss injection to ...
CNBC· 2 日前Shares of Viking Therapeutics jumped 28% on Thursday after the biotech company < ...
Gilead’s HIV Prevention Drug Isn’t Coming Fast Enough for Activists
Bloomberg· 2 日前... pressure to speed up its plans to bring an experimental HIV prevention drug</ ... ...
Growth Portfolio Will Likely Drive Bristol Myers Squibb's Q2
Forbes· 2 日前The company should benefit from continued market share gains for its growth portfolio ... ...
Should You Pick Roche Stock Around $40 After Positive Data For Its Obesity Drugs?
Forbes· 5 日前The stock price of Roche (OTCMKTS: RHHBY) is up 10% in a week, compared to around ...
Meet America’s Best Employers For Women 2024
Forbes· 4 日前For Anne Roemer, a mother of twins and NASA’s deputy human capital officer, that juggle is ...
Two Dozen Patients Are Worth Billions in Pharma’s Hottest Market
Bloomberg· 4 日前The 25 people in Roche Holding AG’s obesity pill study would barely be enough to field both ...
Only 27% Of U.S. Cannabis Businesses Are Profitable, Survey Shows
Forbes· 23 小時前Businesses across the country were surveyed in June, and analysts compiled data on ...
Cheap Ozempic Copycats Are Suddenly Everywhere. Are They Safe?
Bloomberg· 3 日前Cheap Ozempic Copycats Are Suddenly Everywhere. Listen to the Big Take podcast to find out why ...